Biogen Inc.

Pharmaceuticals
United States
Executive 1Dr. Stelios Papadopoulos, Ph.D., Chairman; | Chairman;
Executive 2Dr. George A. Scangos, Ph.D., Chief Executive Officer; | Vice-Chairman;
Earnings Per Share Growth (%)58.39%
Cost of Goods Sold (US$ Millions)$1,171
Current Liabilities (US$ Millions)$2,220
Total Assets (US$ Millions)$4,673
Long Term Debt (Millions)$582
Return on Equity34.05%
Revenue (US$ Millions)$8,508
Total Company Assets$14,317
Revenue Growth (%)46.53%
Net Income (US$ Millions)$2,935
Earnings Per Share (US$)$12.37
Total Equity (US$ Millions)$10,809
Profit Margin (%)34.49%
Debt To Equity Ratio (%)0.05%
Inventories (Millions)$804